Ransom Advisory, LTD Charles River Laboratories International, Inc. Transaction History
Ransom Advisory, LTD
- $202 Billion
- Q1 2025
A detailed history of Ransom Advisory, LTD transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ransom Advisory, LTD holds 131 shares of CRL stock, worth $18,802. This represents 0.01% of its overall portfolio holdings.
Number of Shares
131Holding current value
$18,802% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CRL
# of Institutions
651Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$876 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$730 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$615 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$343 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$280 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...